Recce aims to start human clinical trials in Q3/4 of 2017. Follow progress by signing up.

Register for updates

Contact Form

Required *

Contact

Company Information

Company Information:
Head Office - Sydney

Level 34, 50 Bridge St
AMP Centre
SYDNEY NSW 2000
AUSTRALIA

Telephone: +61 (2) 8216 0768
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

R&D Center - Perth

Suite 10, 3 Brodie Hall Dr  
Technology Park
PERTH WA 6102
AUSTRALIA

Telephone: +61 (8) 9253 9800
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

United States Operations

1717 Pennsylvania Avenue NW,
Suite 1025, WASHINGTON DC
20006 USA 

 

Investor and Media Contacts 

Andrew Geddes
CityPR
Tel: +61 (2) 9267 4511
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Sue Charles/Daniel Gooch
Instinctif Partners
Tel: +44 (0)20 7866 7905
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Clinical Trial Enquiries

Recce aims to start human clinical trials in Q3/4 of 2017. Please register for updates to follow our progress and receive news of our progress towards the start of clinical studies. 

 

Contact image

Sign up for news and updates

Receive news and information direct to your inbox.